It is well known that dramatic lipid-lowering therapies, such as statins or PCSK9 inhibitors, improve atherosclerosis in humans and mice [31,32], and that atherosclerosis has a strong inflammatory component [33]. The gene discussed is PCSK9; the disease is atherosclerosis.